Company Inyx, Inc.

Equities

IYXI

US4618681013

Pharmaceuticals

Market Closed - OTC Markets 11:24:57 2024-04-15 am EDT 5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for Inyx, Inc. 0.00% +9,900.00%

Business Summary

Inyx, Inc. is a provider of specialty pharmaceutical products and technologies. Its operations are focused on the development of both prescriptions, over the counter pharmaceutical products, and specialty consulting services. Also, the Company utilizes niche drug delivery capabilities to develop its own products. The product and service categories of the Company include Metered Dose Inhalers (MDIs) (CFC & HFA), Dry Powder Inhalers (DPIs), Metered Dose Pump Sprays (nasal and oral), Hydrocarbon Foam Aerosols, Saline Aerosols, Sterile Solutions/Injectables, Solid Dose, Formulation Services, Analytical Development Validation, Stability Services, Regulatory Support and Integrated Project Management.

Number of employees: 572

Sales per Business

USD in Million2004Weight2005Weight Delta
Aerosol Pharmaceutical Products and Drug Delivery Technologies
100.0 %
16 100.0 % 50 100.0 % +215.72%

Sales per region

USD in Million2004Weight2005Weight Delta
United Kingdom
48.2 %
-- 24 48.2 % -
United States
34.9 %
16 100.0 % 17 34.9 % +10.05%
Europe
13.7 %
-- 7 13.7 % -
North America
2.4 %
-- 1 2.4 % -
South America
0.7 %
-- 0 0.7 % -
Australia/New Zealand
0.2 %
-- 0 0.2 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 53,717,111 53,106,650 ( 98.86 %) 610,461 ( 1.136 %) 98.86 %

Shareholders

NameEquities%Valuation
Pennsylvania Avenue Advisers LLC
0.3161 %
167,850 0.3161 % - $
Quaker Funds, Inc.
0.3161 %
167,850 0.3161 % - $

Company contact information

Inyx, Inc.

825 Third Avenue 40th floor

10022, New York

+

address Inyx, Inc.(IYXI)